Nanosphere's 2013 Revenues Nearly Double but Loss Widens | GenomeWeb

NEW YORK (GenomeWeb News) – Nanosphere today said that revenues for full-year 2013 nearly doubled year over year, matching the consensus Wall Street estimate on the top line.

The Northbrook, Ill.-based firm said that it recorded $10.0 million in revenues for the year, up from $5.1 million in 2012. All revenues were derived from product sales, while grant and contract revenues declined to none in 2013 from $44,000 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.